VERO-METHOTREXATE®

METHOTREXATE
VERO-METHOTREXATE®

Available Presentations:

  • LYOPHILIZATE FOR SOLUTION FOR INJECTION, VIALS, 500 mg and 1000 mg
  • SOLUTION FOR INJECTION, 5 mg/mL, VIALS, 10 mg/2 mL; SOLUTION FOR INJECTION 10 mg/mL, VIALS, 50 mg/5 ml
INN: methotrexate
Presentation:
Lyophilizate for solution for injection, vials, 500 mg and 1000 mg
Solution for injection, 5 mg/mL, vials, 10 mg/2 mL; solution for injection, 10 mg/mL, vials, 50 mg/5 mL
ATC Group: L01BA01
Product for chemotherapy of malignant neoplasms, anti-metabolite
Scope of Application: treatment of malignant neoplasms of different localizations, treatment of severe forms of psoriasis, rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis
Status of Administration: prescription only
VED Status: listed in VED List
Marketing Authorization: РN 002098/03, PN 002098/02
Shelf Life: 3 years
Conditions of Storage: lyophilizate: at or below 30°C; solution: at or below 25°C

THE INFORMATION ON THIS PAGE IS NOT AN ADVERTISEMENT AND IS INTENDED TO INFORM ON THE PRODUCTS MANUFACTURED BY THE COMPANY.

THE MEDICINAL PRODUCTS HAVE CONTRAINDICATIONS, CONTACT YOUR DOCTOR.